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Introduction
Innate immune factors produced by epithelial cells serve defen-
sive and homeostatic functions and also regulate the inflamma-
tory response following physical and biochemical tissue stress 
(1, 2). Collectin-11 (CL-11, also known as CL-K1 and encoded by 
COLEC11) is a recently described component of innate defense 
that is synthesized by several types of nonimmune cells, including 
epithelial cells of the renal tract and mucosal cells in the intestinal 
and bronchial tracts (3, 4). The collectin family of innate immune 
molecules to which CL-11 has been assigned (5) are soluble C-type 
lectins involved in pattern recognition and include mannan-bind-
ing lectin (MBL) and the surfactant proteins SP-A and SP-D (6, 7).
The structure of CL-11 consists of a globular head, followed 
by a neck region and an N-terminal collagenous domain (5). Each 
chain associates to form trimeric CL-11 subunits that combine to 
give CL-11 oligomers (100–200 kDa). This oligomerization con-
tributes to the high avidity of interaction with monosaccharide 
ligands. The globular head of CL-11 contains a carbohydrate rec-
ognition domain (CRD), which is reported to preferentially bind 
L-fucose among other possible ligands (5). The collagenous region 
of CL-11 contains a binding motif for the MBL-associated ser-
ine proteases MASP-1, MASP-2, and MASP-3 (3, 8), whose func-
tions can initiate the complement cascade but may also involve 
substrates other than complement (9, 10). Like MBL, CL-11 can 
interact with the surfaces of bacteria, viruses, and fungi, which 
indicates a significant role for CL-11 in host defense (3, 8, 11). How-
ever, there are certain biological differences between CL-11 and 
MBL that could affect the respective roles of these molecules at 
different tissue sites. The plasma concentration of CL-11 (12, 13) 
is approximately one-tenth the concentration reported for MBL 
(2 μg/ml), albeit in a different study population (14). In addition, 
whereas MBL mainly originates by hepatocyte synthesis (15), 
CL-11 is synthesized at multiple tissue sites including the liver, 
brain, and heart, as well as in those systems cited above (3, 4, 11).
CL-11 plays a role in host defense, directing the innate 
immune response against locally invasive pathogens (3, 8, 11). A 
role in embryogenesis is apparent in individuals with inherited 
deficiency of CL-11, who have craniofacial birth defects and 
developmental abnormalities of the heart, kidneys, and other 
tissues (16). As a group, collectins also contribute to the mod-
ulation of inflammatory and adaptive immune responses (9, 
10). We speculated that, since animal lectins are involved in a 
broad range of pathophysiological processes, CL-11 could act as 
an inflammatory trigger through recognition of undefined car-
bohydrate structures on stressed cells close to the site of CL-11 
production. In the present study, we examined the relationship 
between cell stress, CL-11 production, ligand binding and acti-
vation of the innate immune system, using a well-characterized 
model of renal tubule cell injury caused by induction of hypoxic 
and hypothermic stress (17–19).
Results
CL-11 mediates tissue injury following renal stress. To investigate the 
pathophysiological role of CL-11, we used an established model 
of ischemic injury with known sensitivity of renal epithelial cells 
to hypoxic stress and a defined role of complement, in particular 
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along the basal surface of viable renal tubules where CL-11 and 
C3d were colocated (Figure 3, K and L). We conclude that the 
early component of postischemic injury was CL-11 dependent 
and involved concomitant accumulation of C3d on the tubule 
surface, regardless of tubule necrosis.
In subsequent studies, we combined minimal ischemia (30 
minutes) with minimal reperfusion (30 minutes) in order to char-
acterize the distribution of CL-11 and the associated ligand at 
potential sites targeted by complement, close to the time of the 
onset of tubule injury. We observed a wide distribution of CL-11 
across the cortex and medulla, with maximal ischemia-induced 
expression in tubules of the inner cortex (Supplemental Figure 3). 
L-fucose, the putative ligand for CL-11, was limited in expression 
to the renal cortex (Supplemental Figure 4). Complement activa-
tion marked by C3d predominantly occurred on tubules within 
the renal cortex (Supplemental Figure 5). Finer mapping within 
the hypoxia-sensitive region of the renal cortex was possible using 
confocal microscopy with segment-specific markers that differen-
tiated between the proximal and distal segments of renal tubules 
(Supplemental Figure 6). While CL-11 was expressed in both the 
proximal tubule (L-fucose–positive, NCC-negative) and distal 
tubule (L-fucose–negative, NCC-positive) segments in the ische-
mic cortex, we mainly detected complement activation (C3d) on 
proximal tubules, where L-fucose and CL-11 were coexpressed. 
Although distal tubules expressed CL-11, there was no L-fucose 
expression and no major involvement of complement. Specifi-
cally, 94% of proximal tubules seen in the cross section were C3d 
positive, while most distal tubule sections (80%) were C3d nega-
tive (Supplemental Figure 6C). In short, complement activation in 
the ischemia-sensitive zone was selective for tubule segments that 
expressed both CL-11 and its putative binding ligand.
Our data establish that ischemic renal injury is CL-11 depen-
dent, but do not distinguish between the possible contribution 
of kidney-derived CL-11 and systemic CL-11 produced by non-
renal sources. To isolate the effect of kidney-derived CL-11, we 
conducted a renal transplantation study in mice. For kidneys 
transplanted from Colec11+/+ or Colec11–/– donors into syngeneic 
Colec11+/+ recipients, we induced cold ischemia (25 minutes), fol-
lowed by an obligatory period of warm ischemia (30 minutes) 
during the implantation procedure. In the first group of mice, we 
removed the kidney 24 hours after transplantation to capture the 
peak injury for histological analysis. Colec11–/– transplants showed 
strong protection from renal tubular damage compared with that 
observed in Colec11+/+ control transplants (Figure 4, A and B). In a 
second group of transplant recipients, we removed the remaining 
native kidney 6 days after transplantation, so that the subsequent 
BUN measurement would reflect the function of the transplanted 
kidney. Although by this stage the renal transplant was recovering 
from the ischemia-reperfusion insult, we were able to confirm that 
the function and structure of Colec11–/– transplants were superior to 
what was observed in the Colec11+/+ controls (Figure 4, C and D). 
Hence, kidney-derived CL-11 was a determinant of both the peak 
injury and the rate of recovery following ischemic insult.
Epithelial cell stress causes binding of CL-11. Given the poten-
tial link between postischemic injury and kidney-derived CL-11 
emerging from the transplantation and localization studies, we 
explored the specific role of the renal tubule cell. We used pri-
the central component C3 (20). We induced reperfusion injury 
in C57BL/6 WT mouse kidneys following a 50-minute period of 
renal vessel ligation and charted the expression of CL-11 in renal 
tissue at early time points. This confirmed the basal expression of 
Colec11 mRNA in normal, nonmanipulated mouse kidney (4) and 
showed rapid upregulation of CL-11 in the cortex of postischemic 
kidney, where peak expression of Colec11 mRNA occurred within 
6 hours of reperfusion (Figure 1, A and B). Immunofluorescence 
localization of CL-11 at 6 hours after reperfusion detected CL-11 
within the cytoplasm and on the cell surface of renal tubular epi-
thelial cells (RTECs) (Figure 1C). Tissue staining for C3d, the 
covalently bound fragment formed after cleavage of C3, showed 
localization of the activated complement fragment on the RTEC 
surface (Figure 1C). The merged immunofluorescence image 
for CL-11 and C3d shows the relationship of these 2 molecules 
detected at the basal surface of the renal tubules in the hypoxia-
sensitive zone at the corticomedullary region of the kidney (Fig-
ure 1D). In addition, we studied the distribution of L-fucose, a 
putative ligand for CL-11, whose expression in normal kidney is 
limited to the cortical tubule segments (21). Our study confirmed 
this distribution in normal tissue (Supplemental Figure 1; supple-
mental material available online with this article; doi:10.1172/
JCI83000DS1) and, in ischemic tissue, revealed a disorganized 
pattern of L-fucose expression, in which L-fucose appeared to be 
aligned with CL-11 along the basolateral border of the corticom-
edullary tubules (Figure 1E).
In a second experiment, we compared the ischemic injuries 
induced in Colec11–/– and WT (Colec11+/+) mice to determine the 
influence of CL-11. On this occasion, we used 50 minutes of ische-
mia and a longer period of reperfusion (24 hours), allowing us to 
measure the impact of CL-11 at the peak injury time (18, 20). We 
found that Colec11–/– mice showed reduced tubule necrosis and 
inflammatory cell infiltration compared with that seen in Colec11+/+ 
mice (Figure 2, A–H). Specifically, infiltration by neutrophils and 
macrophages was reduced in the absence of CL-11. In addition, we 
noted that deposition of complement (C3d) on the kidney tubules of 
Colec11–/– mice was much lower than that observed in Colec11+/+ mice 
(Figure 2, I and J), to an extent that was comparable to that of the 
background staining for C3d detected in nonmanipulated Colec11+/+ 
mouse kidney (Figure 1C and Supplemental Figure 2). Blood urea 
nitrogen (BUN), a measure of renal function, showed substantial 
preservation of function in the protected mice (Figure 2K). Thus, 
CL-11 mediates postischemic tubule damage and interstitial infil-
tration. However, it was not clear from these data alone whether 
complement activation played a primary or secondary role.
To determine whether CL-11 participated in the induction 
of tubule injury or as a reaction to tubule necrosis, we induced a 
milder period of renal ischemia (30 minutes) in a separate group 
of mice and, again, evaluated the injury 24 hours after reperfu-
sion. The results showed a good correlation with the severe model 
(50 minutes of ischemia), since an absence of CL-11 in Colec11–/– 
mice permitted a less severe loss of renal function, with good 
preservation of renal architecture and reduced leukocyte infil-
tration and tubular deposition of complement compared with 
that seen in Colec11+/+ mice (Figure 3, A–I). Furthermore, with 
the less-intense staining for C3d in the Colec11+/+mice using this 
milder injury model, it was possible to more clearly discern areas 
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stressed renal cells (Figure 5, E and F). Thus, the RTEC was both a 
source and a target of CL-11, which, following cell stress, could be 
detected bound to the basal cell surface.
We considered whether cell stress was sufficient to induce 
CL-11 binding at a fixed concentration of CL-11. In this case, we 
used recombinant murine CL-11 (rCL-11) at a physiological con-
centration and used Colec11–/– RTECs to detect CL-11 binding, 
avoiding the background of endogenous CL-11. The clumped and 
polarized pattern of rCL-11 binding on stressed cells (Figure 6, A 
and B) was reminiscent of that detected with a high concentration 
of native CL-11 in the culture supernatant of WT cells. We found 
that binding of CL-11 to the stressed cells was dose dependent 
when we varied the amount of added rCL-11 (0, 150, 300, and 600 
ng/ml) (Figure 6, C and D). We concluded that both the concen-
mary cultures of RTECs derived from Colec11+/+ mouse kidney 
and examined CL-11 production and release following hypoxic 
or hypothermic cell stress. We determined that induction of cell 
stress in vitro, followed by restoration of normal culture condi-
tions, increased both the intracellular and extracellular content 
of CL-11 (Figure 5, A–D). Under these conditions, we detected 
CL-11 on the RTEC at its basal surface using confocal micros-
copy combined with a cell-surface marker of F-actin to localize 
the staining on the outer aspect of the cell (Figure 5D). To detect 
CL-11 released from the cell, we transferred RTEC culture super-
natant to stressed, CL-11–deficient RTECs derived from the KO 
mouse, thereby eliminating the endogenous CL-11 background 
from the assay. These results showed a clumped and polarized 
pattern of CL-11 staining indicative of polyvalent binding to the 
Figure 1. Acute-phase response of CL-11 
and associated molecules in mouse 
kidney. Detection of CL-11 and potential 
ligand (L-fucose) and complement 
activation product (C3d) are shown in 
normal mouse kidney and injured kidney 
after 50 minutes of ischemia and up to 
24 hours of reperfusion. (A) Agarose gel 
image demonstrating Colec11 mRNA 
expression in normal and ischemic 
kidney tissue, determined by semiquan-
titative RT-PCR. Colec11 appears as a 
315-bp product, and Gapdh (453 bp) is 
included as an internal control. M, 100 
bp DNA ladder. n = 2 mice/group. (B) 
Quantification of Colec11 mRNA expres-
sion in normal and ischemic kidney 
tissue by real-time quantitative RT-PCR 
(qRT-PCR) demonstrating upregulation 
of intrarenal Colec11 mRNA expression 
following ischemic insult. Each dot rep-
resents an individual mouse (n = 4 mice/
group). ***P < 0.005, by 1-way ANOVA. 
(C) Representative immunofluorescence 
microscopic images of renal cortex 
showing particulate staining of CL-11 
(red), linear peritubular staining of C3d 
(green), and a merged image of CL-11 
and C3d in normal and ischemic kidney 
tissue (n = 4 mice/group). (D) Enlarge-
ment (original magnification, ×400) of  
white boxed area in panel C, with arrows 
showing coexpression of CL-11 and 
complement deposition (orange) along 
the basolateral border of renal tubular 
epithelium. (E) Representative fluo-
rescence images of CL-11 (red), L-fucose 
(green), and a merged image of CL-11 and 
L-fucose in normal and ischemic kidney 
tissue (n = 6 mice/group) showing ische-
mia-related coexpression of CL-11 and 
L-fucose (orange) along the basolateral 
border of the tubules. Scale bars: 25 μm.
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Figure 2. Impact of CL-11 on renal injury induced by 50 minutes of ischemia. Renal injury and complement activation in Colec11+/+ and Colec11–/– mice 
following 50 minutes of ischemia and 24 hours of reperfusion. (A) Representative images of PAS staining of kidney sections from Colec11+/+ and Colec11–/– 
mice (n = 10 mice/group). Arrow indicates necrotic area of renal tubules seen in a longitudinal section at the junction of the renal cortex and medulla. Scale 
bars: 100 μm. (B) Severity scores for renal tubular injury in the mice represented in A. (C) Representative images of immunochemical staining of neu-
trophils in kidney sections from Colec11+/+ and Colec11–/– mice (n = 4 mice/group). (D) Quantification of neutrophils in kidney sections from the mice repre-
sented in C. (E) Representative images of immunochemical staining of leukocytes in kidney sections from Colec11+/+ and Colec11–/– mice (n = 3 mice/group). 
Scale bars: 100 μm. (F) Quantification of leukocytes in the kidney sections represented in E. (G) Representative images of immunochemical staining of 
macrophages in kidney sections from Colec11+/+ and Colec11–/– mice (n = 3 mice/group). Scale bars: 100 μm. (H) Quantification of macrophages in the kidney 
sections represented in G. (I) Representative images of immunofluorescence staining of C3d in kidney sections from Colec11+/+ and Colec11–/– mice (n = 10 
mice/group). Scale bars: 25 μm. (J) Quantification of C3d in kidney sections from the mice represented in I. (K) BUN levels in Colec11+/+ and Colec11–/– mice 
after reperfusion (n = 10 mice/group). Dashed line represents the BUN baseline in normal, nonmanipulated mice. (B, D, F, H, J, and K) Each dot represents 
an individual mouse. *P < 0.05, **P < 0.01, ***P < 0.005, and ****P < 0.001, by unpaired, 2-tailed Student’s t test.
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incubation with normal mouse serum (NMS) (Figure 8, A and B). 
We then examined the requirement for CL-11 and the associated 
lectin complement pathway enzyme MASP-2 using KO mouse 
sera that individually lack these specific components. Of the 3 
MASPs known to be associated with CL-11, MASP-2 cleaves the 
complement component C4 and C4-bound C2 to form the cen-
tral C3 convertase C4b2a (26). In addition, MASP-2–mediated 
cleavage of C3 can occur through a route that is independent of 
C4. The first report on the existence of this so-called C4 bypass 
was based on the analysis of C4-deficient mouse serum and 
C4-deficient human serum from a patient who was deficient in 
the human C4 genes C4A and C4B (26). In that report, reduced 
but clearly measurable lectin pathway–dependent cleavage of C3 
was detected and could be inhibited by either adding MASP-2 
inhibitory Abs or fluid-phase ligands to block lectin pathway–rec-
ognition subcomponents. C4-independent activation of C3 that 
is mediated by MASP-2 has also been described in several models 
of ischemia-reperfusion injury (IRI) including postischemic kid-
ney injury (26, 27). Therefore, we examined the requirement for 
C4 in the present study as well as the need for CL-11 and MASP-2 
in triggering complement activation on RTECs.
With either CL-11 or MASP-2 missing from the experimental 
protocol, we found that complement (C3d) deposition from the 
serum largely failed (Figure 8, A and B). This indicated that both 
of these molecules were essential for enabling the conversion 
of C3 into its active form and promoting C3d formation on the 
injured cells, suggesting that the lectin complement activation 
pathway plays a key role in initiating complement activation. 
By contrast, complement deposition from C4-deficient mouse 
serum was unrestrained compared with that detected in NMS 
(Figure 8, A and B), suggesting that MASP-2 used the C4-bypass 
route to cleave C3 in this model (26, 27).
Having established that CL-11 was indispensable for trigger-
ing complement activation on the injured tubule cell, we asked 
whether it was the cell-bound or fluid-phase fraction of CL-11 that 
was essential. To resolve this question, we enzymatically removed 
L-fucose from the surface of stressed Colec11–/– RTECs, thereby 
preventing the majority of CL-11 and C3d binding in NMS (Figure 
8, C and D). By contrast, galactosidase-treated RTECs retained 
the ability to bind CL-11 and deposit C3d (Figure 8, C and D). The 
merged images for CL-11 and C3d showed strong colocalization 
of these 2 molecules (Figure 8C), indicating that complement 
was largely deposited at the site of CL-11 binding. In addition, we 
sought independent evidence that the membrane-bound fraction 
of CL-11 could trigger complement activation. Stressed Colec11–/– 
RTECs were coated with rCL-11 and washed to remove unbound 
rCL-11, followed by incubation of the washed cells with CL-11–defi-
cient serum and detection of bound C3d. We found that substan-
tial formation of C3d only occurred when the cells were pretreated 
with CL-11 (Figure 8, E and F).
This meant that both the cell-surface presentation of L-fucose 
and attachment of CL-11 were necessary to initiate MASP-2–
mediated cleavage of C3 in the context of renal tubule cell stress.
Discussion
While there is a broad understanding of the effector pathways that 
can mediate postischemic renal injury (28), the precise nature of 
tration of CL-11 in the extracellular space and the capacity of the 
stressed cell for CL-11 binding contributed to the complex pattern 
of interaction between CL-11 and the basal cell surface. Hypoxia- 
and hypothermia-induced patterns of CL-11 binding were indis-
tinguishable in our experiments.
Human epithelial cells showed properties similar to those 
of mouse cells. We studied a transformed cell line derived 
from human RTECs (hRTECs), whose growth as suspension 
cells permitted the analysis of CL-11 binding by flow cytometry 
(22). We observed constitutive expression of CL-11 in permea-
bilized hRTECs (Supplemental Figure 7A). In addition, using 
nonpermeabilized cells to which rCL-11 had been added, we 
detected a dose-dependent increase in CL-11 binding on the cell 
(Supplemental Figure 7B). Thus, human cells can produce and 
bind CL-11, a finding that verifies the results with murine cells 
derived by primary culture and agrees with the reported expres-
sion of CL-11 in human renal tissue (3, 11).
L-fucose recognition by CL-11 on stressed cells. The specificity 
with which CL-11 can detect soluble or immobilized monosaccha-
ride has been the subject of recent reports, which indicated that 
L-fucose was the preferred ligand for both human and murine 
CL-11 (3, 11). L-fucose is a constituent of many N- and O-linked 
glycoproteins and glycolipids that are produced by mammalian 
cells and can be present on the cell membrane or glycocalyx (23). 
Accordingly, we examined whether L-fucose could be the cellular 
ligand recognized by CL-11 in our experiments. We preincubated 
rCL-11 with soluble L-fucose, and in control studies, we used sol-
uble D-galactose (which has minimal relevance to CL-11) (3). We 
then measured the ability of the monosaccharide-treated rCL-11 
to bind to stressed Colec11–/– RTECs. While L-fucose treatment 
substantially prevented CL-11 binding to RTECs, D-galactose 
caused no major loss of CL-11 binding (Figure 7, A and B). This 
suggested that detection of L-fucose by the CRD on CL-11 was 
important for CL-11 binding to stressed renal tubule cells.
To verify that L-fucose on mammalian cells acts as a novel 
stress-associated binding ligand for CL-11, we treated stressed 
murine RTECs with fucosidase to specifically remove L-fucose 
from the cell surface (Figure 7C). We then examined the fucose- 
denuded cells (or control cells treated with galactosidase) for the 
ability to bind CL-11 after the addition of rCL-11. The fucose- 
denuded cells showed an extensive reduction of CL-11–binding 
capacity, while those pretreated with galactosidase showed no 
loss of CL-11 binding (Figure 7, D and E). Hence, the presentation 
of L-fucose on the stressed RTEC surface was required to induce 
significant CL-11 attachment, consistent with the colocalization of 
these 2 molecules in postischemic kidney (Figure 1E).
CL-11-ligand interaction triggers complement activation on 
stressed cells. We constructed an in vitro assay to test the hypoth-
esis that complement activation on stressed renal tubule cells is 
initiated by CL-11 binding, which was suggested by the observed 
ability of C3d and CL-11 to localize at the site of tubule injury 
(Supplemental Figures 5 and 6). We exploited the recognized 
property of renal tubule cells to deposit complement from normal 
human serum, which contains the necessary complement com-
ponents and activating factors to achieve cleavage of C3 into its 
active form (24, 25). We first confirmed this property in murine 
cells by showing that C3d was formed on stressed RTECs upon 
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stress-induced tissue changes and the associated molecules that 
initiate these responses are less certain. Here, we describe how 
CL-11 functions as a pattern-recognition molecule whose interac-
tion with stress-inducible L-fucose on renal epithelial cells incites 
an inflammatory and tissue-destructive response. Two aspects of 
CL-11 function are at play: the detection of an aberrant pattern of 
carbohydrate that is linked to cell stress and the triggering of the 
complement cascade at the site of lectin attachment (Figure 9). 
Our results therefore identify CL-11 as a tissue-derived molecular 
trigger that initiates complement activation and local inflamma-
tory responses relevant to acute kidney injury.
Our study defines L-fucose as a damage-associated ligand 
that is presented on epithelial cells following hypoxic or hypo-
thermic conditions. L-fucose is a constituent of many glycans 
that are produced by mammalian cells and expressed on the cell 
membrane or glycocalyx coat (23). In ischemic tissue, we found 
an abnormal pattern of L-fucose expressed at the basolateral 
border of proximal tubules cells, in association with CL-11 and 
complement deposition. A display of the aberrant carbohydrate 
pattern was essential to fully induce CL-11 binding and com-
plement activation on cultured renal tubule cells. We deduced 
that L-fucose was the primary ligand recognized by CL-11 on 
injured tubule cells, given the observation that blockade of the 
interaction of L-fucose with CL-11 prevented CL-11 binding and 
complement activation in our model. Mannose is another pos-
sible ligand recognized by CL-11 (3). However, our studies only 
detected mannose on the luminal surface, away from the basal 
surface targeted by complement in ischemic tissue (Supplemen-
tal Figure 8). The molecular identity of the fucose-bearing glyco-
lipid or glycoprotein that was recognized by CL-11 on the tubule 
cells remains unclear. This will be an important factor in deci-
phering whether a change in orientation or exposure of the CL-11 
ligand or an increase in ligand density and pattern of distribution 
are required to induce efficient binding of CL-11 on damaged 
cells. Work is underway to resolve this question.
Collectins such as MBL, SP-A ,and SP-D are multifunctional 
molecules that can trigger several independently operating effec-
tor responses of the innate immune system (6, 7, 9, 10). The pres-
ent study identifies complement as one such effector mechanism 
triggered by CL-11 on RTECs. Previous work has shown that CL-11 
isolated from human serum is physically associated with the serine 
proteases MASP-1, MASP-2, and MASP-3, which are required for 
lectin complement pathway activation (3, 8). Our data suggest that 
the pathway of complement activation triggered by CL-11 on tubule 
cells used MASP-2, leading to cleavage of C3 via a C4-independent 
route. Complement activation that proceeds through MASP-2 but 
does not subsequently require C4 has been reported in several organ 
models of stress-induced injury including postischemic injury of the 
heart, intestine, and kidney (26, 27). Since CL-11 is expressed within 
these organs (3, 4, 11), it is possible that CL-11–mediated lectin path-
way activation underpins a common trigger mechanism. In contrast 
to CL-11, we found no evidence to support a significant role of MBL 
in our model, since complement deposition on cells largely failed 
when CL-11 was absent, even though MBL was present (in serum) 
in our experiments.
Our results do not exclude a secondary role for the alternative 
complement pathway, which in previous studies was shown to 
mediate ischemic acute renal failure in mice (29, 30). C3b formed 
by the lectin pathway could initiate alternative complement path-
way activation by binding to native factor B, thereby enabling 
factor D to cleave C3bB and form the alternative pathway C3 con-
vertase C3bBb (31). Additionally, the lectin pathway proteases 
MASP-1 and MASP-2 could synergistically promote alternative 
pathway activation by converting pro–factor D, the zymogen form 
of factor D, into its enzymatically active form (32, 33). In our study, 
it is therefore feasible that alternative pathway activation could 
have substantially increased the amount of complement deposi-
tion following initiation of the lectin pathway through CL-11. This 
may explain the disproportionate quantity of C3d relative to CL-11 
we detected along the lateral border of the renal tubule in ischemic 
studies. Moreover, “tick-over” activity of the alternative pathway 
could have accounted for the residual amount of C3d deposited 
when CL-11 was absent from the experiment. Future studies in 
mice with combined deficiency of the lectin and alternative path-
ways will be useful in addressing these subsidiary mechanisms 
and their dependence on CL-11.
CL-11 and CL-10 are detected in normal human serum as 
CL-11 and CL-10 heterotrimers alongside CL-11 and CL-10 
homotrimers (34). It was reported that interchain disulphide bonds 
held together the CL-10 and CL-11 single chains, implying that 
such heterotrimers can only form within a cell that synthesized 
both components (34). So far, the only known cell in which CL-11 
and CL-10 are coexpressed is the hepatocyte. We therefore did not 
examine CL-10 in our study, since the published results claim that 
only CL-11 is expressed by renal tissue. The specific physiological 
role of the CL-10 and CL-11 heterotrimers is unknown. However, 
from our perspective, the absence of CL-11 in the gene-targeted 
mouse strain that we analyzed gave us the opportunity to demon-
Figure 3. Impact of CL-11 on injury induced by milder ischemic insult. Renal injury is shown for Colec11+/+ and Colec11–/– mice following 30 minutes of 
ischemia and 24 hours of reperfusion. (A) Representative images of PAS staining of kidney sections from Colec11+/+ and Colec11–/– mice (n = 8 mice/group). 
Arrow indicates necrotic renal tubules seen in a longitudinal section at the corticomedullary junction. Scale bars: 100 μm. (B) Severity scores for renal 
tubular injury in the mice represented in A. (C) Representative images of immunochemical staining of neutrophils in kidney sections from Colec11+/+ and 
Colec11–/– mice (n = 3 mice/group). Scale bars, 100 μm. (D) Quantification of neutrophils in the kidney sections represented in C. (E) Representative images 
of immunochemical staining of leukocytes in kidney sections from Colec11+/+ and Colec11–/– mice (n = 3 mice/group). Scale bars: 100 μm. (F) Quantification 
of leukocytes in the kidney sections represented in E. (G) Representative images of immunochemical staining of macrophages in kidney sections from 
Colec11+/+ and Colec11–/– mice (n = 3 mice/group). Scale bars, 100 μm. (H) Quantification of macrophages in the kidney sections represented in panel G. (I) 
BUN levels in Colec11+/+ and Colec11–/– mice after reperfusion (n = 8 mice/group). Dashed line represents the BUN baseline in normal, nonmanipulated mice. 
(J) Representative immunofluorescence microscopic images of CL-11 (red) and C3d (green) and a merged image of CL-11 and C3d in ischemic kidney tissue. 
Scale bars: 25 μm. (K and L) Enlarged images (original magnification, ×400) of the merged image in J. Arrows indicate where the linear deposit of comple-
ment is dotted with CL-11 (orange) along the basolateral surface of the tubular epithelium, which is best appreciated at higher magnification. (B, D, F, H, 
and I) Each dot represents an individual mouse. *P < 0.05, ***P < 0.005, and ****P < 0.001, by unpaired, 2-tailed Student’s t test.
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tion (by hepatocytes) and formation of large circulating oligomers 
(200–600 kDa) may prevent MBL from having a significant bio-
logical role at some extravascular sites (6).
Our findings leave little doubt that the proximal tubule cell 
was the source of the CL-11 involved in the mediation of postisch-
emic renal injury. The transplantation studies identified an impor-
tant contribution of kidney-derived CL-11, while segment-specific 
mapping studies showed that only proximal tubule cells expressed 
the combination of CL-11 and L-fucose that was required to trigger 
lectin complement pathway activation. We do not claim that CL-11 
interaction with its major ligand L-fucose was the sole mecha-
nism of complement activation on hypoxia-sensitive tubules, 
since background levels of complement activation occurred in the 
absence of CL-11 and minor complement deposition affected the 
distal tubules independently of L-fucose. Nonetheless, our results 
establish the idea that complement deposition was predominantly 
associated with the proximal tubule, where the molecular com-
ponents required for lectin pathway activation were coexpressed. 
Tubule segment–specific deletion of CL-11 could provide a future 
means to corroborate these findings and possibly discover other 
functions of CL-11 in different segments of the tubule.
In conclusion, CL-11 is a soluble C-type lectin with wide tissue 
distribution and can be produced locally in renal epithelial cells 
to initiate complement activation following cell-autonomous 
interaction with stress-induced ligand (L-fucose). The broad 
expression of CL-11 (3, 4, 11) and its putative ligands (3, 11) makes 
it possible that CL-11 operates on a wider scale, promoting inflam-
mation and immunity in other organs and conditions. Further-
more, the simplicity with which soluble monosaccharide inhib-
strate that it is the locally produced CL-11 in the kidney that trig-
gers renal ischemic injury in a MASP-2–dependent fashion, since 
our transplantation experiments clearly show that the implantation 
of Colec11–/– kidneys into CL-11–sufficient (and CL-10–sufficient) 
WT mice achieves a significant degree of protection against ische-
mia-reperfusion damage. It is therefore not plasma-derived CL-11 
that triggers the lectin pathway within the ischemic kidney. Fur-
thermore, it is clear from our in vitro studies using recombinant 
CL-11 added to cultured renal tubule cells that CL-11 reacts directly 
with the L-fucose presented by target cells.
Susceptibility of renal tubule cells to complement-mediated 
injury is associated with a number of factors. These epithelial cells 
express the central complement component C3 (18, 35, 36), which, 
when cleaved, leads to formation of the membrane attack com-
plex C5b-9 and release of C5a (18, 20). Both of these complement 
effectors stimulate proinflammatory responses in epithelial cells 
and infiltrating leucocytes and can mediate cell death (17, 37, 38). 
In addition, renal tubule cells show relatively weak expression of 
cytoprotective complement regulators that inhibit cleavage of C3 
into its active state, which means the cells have a low injury thresh-
old (39). Here, we show that, in addition to these factors, renal 
tubule cells can release CL-11, which, in the presence of cell stress, 
can initiate complement activation on the tubule surface. Since 
cultured cells deposited minimal complement in the absence of 
CL-11, this indicates that the lectin pathway activation triggered 
by CL-11 was the primary route of complement activation on these 
cells. The cell-autonomous action of CL-11 reported here in the 
context of epithelial cell stress is distinct from the potential action 
of other systemic collectins such as MBL, whose central produc-
Figure 4. Contribution of kidney-derived CL-11 in post-transplantation ischemic injury. Quantifi-
cation of histological injury and/or renal dysfunction is shown for Colec11+/+ mice transplanted with 
kidneys from Colec11+/+ or Colec11–/– littermates. The donor organ was kept on ice for 25 minutes 
prior to implantation. (A) Histology with PAS staining 24 hours after transplantation representing 
the peak of injury (n = 2 mice/group). Enlarged panel (original magnification, ×200) with an arrow 
illustrates necrotic renal tubules seen in a longitudinal section. Scale bars: 100 μm. (B) Severity scores 
for the renal tubular injury represented in A. (C) BUN measurement in the recovery phase on day 7 
after transplantation for recipients of Colec11+/+ or Colec11–/– donor kidneys, following the remaining 
native nephrectomy on day 6 (n = 6 mice/group). Dashed line represents the BUN baseline in normal, 
nonmanipulated mice. (D) Severity scores for the renal tubular injury in mice represented in C.  
*P < 0.05 and **P < 0.01, by unpaired, 2-tailed Student’s test.
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II (Lorne Laboratories); Texas red phalloidin (Molecular Probes); cell 
culture medium (DMEM/F12), FCS, and ITS (mix of insulin, transfer-
rin, and selenium) (Invitrogen); hydrocortisone, triiodothyronine, and 
enzymes (i.e., L-fucose, D-galactose, L-fucosidase, and β-gal) (Sig-
ma-Aldrich); and rCL-11 (Stratech Scientific).
Animals. WT and KO mice with deficiencies of CL-11, MASP-2, or 
C4 were on a C57BL/6 background (27, 40, 41). Homozygous CL-11–
KO (Colec11–/–) mice were purchased from Mutant Mouse Resource and 
Research Centers (MMRRC) (UC Davis, Davis California, USA) (40). 
WT littermates (Colec11+/+) were used as controls. Male mice (~22 g BW; 
6–8 weeks of age) were used in all experiments. All mice were main-
tained in specific pathogen–free conditions.
Induction of renal IRI. Renal IRI was induced as we described pre-
viously (20). Briefly, mice were anesthetized by inhalation of isofluo-
rane and kept warm on a heated pad. An abdominal incision was per-
ited CL-11 binding to targeted epithelial cells in our study could 
suggest a physiological control mechanism that merits further 
exploration and exploitation.
Methods
We used the following reagents and materials: isofluorane (Abbott); 
microaneurysm clamps (Codman); urease kit (BUN Infinity); and 
Vivaspin ultrafiltration spin columns (Fisher Scientific); polyclonal goat 
anti-human CL-11 Ab (S14; Santa Cruz Biotechnology Inc.); polyclonal 
rabbit anti-human C3d Ab (A0063; Dako) and HRP-conjugated rab-
bit anti-rat Ig Ab (P0450; Dako); rat anti-mouse Ly-6B.2 mAb (clone 
7/4; AbD Serotec); donkey anti-goat Alexa Fluor 568 Ab (A11057; 
Invitrogen); FITC-conjugated goat anti-rabbit IgG Ab (111-095-144; 
Stratech Scientific); DAPI (Life Sciences); fluorescein-conjugated 
lotus tetragonolobus lectin (LTL) (Vector Laboratories); collagenase 
Figure 5. Renal tubule cell stress mediates CL-11 expression. (A) Representative immunofluorescence images of intracellular CL-11 in nonstressed and 
hypoxia-stressed RTECs or in hypothermia-stressed Colec11+/+ RTECs (permeabilized). CL-11 (red) and nuclei (blue) are shown. Scale bars: 10 μm. (B) Quantifi-
cation of intracellular CL-11 in the RTECs shown in A. Data shown are from 6 individual images and representative of 4 independent experiments. (C) Relative 
Colec11 mRNA levels in nonstressed and hypothermia-stressed Colec11+/+ RTECs, as determined by qRT-PCR (n = 3). Data are representative of 2 experiments. 
*P < 0.05, by unpaired, 2-tailed Student’s t test. (D) Confocal microscopic image of CL-11 in hypothermia-stressed Colec11+/+ RTECs (nonpermeabilized). CL-11 
(green), F-actin (red), and nuclei (blue) are shown. Views in the bottom and side panels show that CL-11 was present at the basal cell surface. (E) Representa-
tive immunofluorescence images of bound CL-11 in Colec11–/– RTECs that had been hypoxia stressed and then incubated with supernatants from nonstressed 
(Nonstressed sup) or hypoxia-stressed (Stressed sup) Colec11+/+ RTEC cultures or nonstressed Colec11–/– RTEC cultures (negative control), demonstrating that 
the supernatants from Colec11+/+ RTEC cultures had CL-11–binding activity. Scale bars: 25 μm. (F) Quantification of bound CL-11 in the RTECs represented in E. 
Data shown are from 7 individual images and representative of 2 independent experiments. (B and F) ****P < 0.001, by 1-way ANOVA.
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ment of renal function and tissue damage, respectively. In separate 
experiments, recipients were killed 24 hours after successful trans-
plantation so that the peak injury could be assessed histologically. 
This procedure is associated with a mortality rate of 10% or lower.
Assessment of renal function. Following the preparation of serum 
from collected blood, BUN was assessed using a standard urease kit 
(BUN Infinity) that measured coupled enzyme reactions involving 
urease and glutamate dehydrogenase.
Assessment of renal histopathology. Kidneys were fixed in a solu-
tion of 4% formalin in PBS for 24 hours and embedded in paraffin. 
Paraffin sections (2 μm) were stained with periodic acid-Schiff (PAS). 
The severity of tubular injury at the corticomedullary junction was 
graded in a blinded fashion by 2 experimenters who used the following 
5-point scale: 0, normal kidney; 1, less than 10% necrosis; 2, 10%–25% 
necrosis; 3, 25%–75% necrosis; and 4, more than 75% necrosis, as we 
described previously (20).
Immunochemical staining of kidney tissues. Frozen sections (4 μm) 
of OCT-embedded kidneys were air dried and then acetone fixed. Sec-
tions were incubated with polyclonal goat anti-human CL-11 Ab (1:100; 
Santa Cruz Biotechnology Inc.), which cross-reacts with mouse CL-11; 
polyclonal rabbit anti-human C3d Ab (1:200; Dako) or rat anti-mouse 
Ly-6B.2 mAb (1:100; Serotec); rat anti-mouse CD45 Ab (clone 30-F11; 
1:100; Caltag); and rat anti-F4/80 Ab (clone BM8; 1:100; Abcam), 
followed by secondary donkey anti-goat Alexa Fluor 568 (Life Tech-
nologies); FITC-conjugated goat anti-rabbit IgG Ab (1:200; Stratech 
Scientific); and HRP-conjugated rabbit anti-rat (for Ly-6B.2, CD45, 
and F4/80; 1:100; Dako), respectively. In all fluorescence immuno-
histochemical assays, cell nuclei were stained with DAPI (1:10,000). 
Markers for distal tubules (renal thiazide–sensitive NaCl cotrans-
porter [NCC]) were detected with polyclonal rabbit anti-human NCC 
formed, and renal arteries and veins were isolated and then bilaterally 
occluded for 50 minutes or 30 minutes using microaneurysm clamps 
that provide the correct amount of pressure to provide complete occlu-
sion without damaging the vessel walls. Following removal of the 
clamps, 0.5 ml warm saline was placed in the abdomen, the incision 
was sutured, and the animals were placed in a warm box to recover. 
Mice were killed at either 6 or 24 hours or 0.5 hours after removal 
of the clamps. Blood samples were taken for the assessment of renal 
function, and kidneys were harvested for histopathology. The moder-
ate severity of injury achieved with 50 minutes of occlusion is associ-
ated with a survival rate of 90% or higher at day 7 after ischemia.
Mouse kidney transplantation. Mice were anesthetized by inhala-
tion of oxygen and isofluorane (Abbott Laboratories) and kept warm 
using a heated mat. The donor kidney was surgically removed along 
with an arterial patch. The renal vein was cut close to the inferior 
vena cava, and the ureter was isolated and cut close to the bladder. 
The kidney was then placed in ice-cold saline for 25 minutes, during 
which time the recipient was anesthetized. The recipient native right 
kidney was removed, and microaneurysm clamps (the same type 
used in the native model of ischemia) were placed to occlude the 
aorta and inferior vena cava (IVC). Incisions were made in the aorta 
and IVC, to which donor artery and vein were anastomosed. The 
period of warm ischemia during the formation of this anastomosis 
lasted for 30 minutes. The clamps were then removed, and the kid-
ney was observed to ensure revascularization. The ureter was con-
nected to the bladder, and 0.5 ml warm saline was placed in the body 
cavity. The abdomen was closed and the animal returned for recov-
ery to a heated chamber for 24 hours. The remaining native kidney 
was excised on day 6 after transplantation, and the animal was killed 
after a further 24 hours. Blood and kidney were collected for assess-
Figure 6. Renal tubule cell stress mediates CL-11 binding. Binding of exogenous CL-11 detected by immuno-
fluorescence staining after incubation of rCL-11 with Colec11/– RTECs is shown. (A) Representative immun-
ofluorescence images of bound rCL-11 in nonstressed and stressed (i.e., hypothermia or hypoxia) Colec11–/– 
RTECs after incubation with rCL-11, showing a clumped CL-11–binding pattern induced by cell stress. The 
negative control consisted of stressed Colec11–/– RTECs that had not been incubated with rCL-11. Scale bars: 
25 μm. (B) Quantification of bound CL-11 corresponding to the RTECs shown in A. Data shown are from 10 
individual images and representative of 3 independent experiments. ****P < 0.001, by 1-way ANOVA. (C) 
Dose titration of rCL-11 binding to stressed RTECs. Representative images show the different CL-11 concen-
trations. Data shown are from 6 to 8 individual images and representative of 2 independent experiments. 
Scale bars: 25 μm. (D) Quantification of bound CL-11 corresponding to the RTECs represented in C. Data were 
analyzed by 1-way ANOVA (P value is indicated in the graph).
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with 5% CO2 for 2 hours. Hypoxia stress was induced by culturing 
RTECs under hypoxic conditions (5% CO2, 1% O2 and 94% N2) in a 
gas chamber (Billups-Rothenberg) for 24 hours, followed by reoxygen-
ation (21% O2 and 5% CO2) for 24 hours.
Detection of endogenous CL-11 in cultured RTECs. To detect the 
synthesis of CL-11 by RTECs, stressed or nonstressed RTECs were 
fixed in 4% paraformaldehyde for 10 minutes at room temperature 
and permeabilized with 0.2% Triton X-100 for 3 minutes. Immun-
ofluorescence for CL-11 was then performed as described earlier. 
To detect the secretion of CL-11 from RTECs, supernatants were 
collected from Colec11+/+ or Colec11–/– (negative control) RTEC cul-
tures and concentrated 20-fold using Vivaspin ultrafiltration spin 
columns. Supernatants were then added to Colec11–/– RTEC monolay-
ers (which were hypoxia stressed) and incubated for 1 hour. The cells 
were then fixed, but not permeabilized, and subjected to immuno-
fluorescence for CL-11.
Detection of exogenous CL-11 binding to cultured RTECs. RTECs cul-
tured from Colec11–/– kidneys were subjected to thermal or metabolic 
Ab (1:300; EMD Millipore), followed by secondary donkey anti-rabbit 
Cy5 Ab (1:200). The detection of L-fucose was achieved using fluores-
cein-conjugated LTL (1:40). Following immunochemical staining of 
neutrophils, infiltration was quantified by counting positively stained 
cells at the corticomedullary junction area, at a magnification of ×200, 
and expressed as the number of neutrophils per field.
RTEC cultures. Primary RTEC cultures grown as a mono-
layer were prepared from kidneys of Colec11+/+ or Colec11–/– mice as 
described previously (42). In brief, minced cortex was digested with 
0.1% collagenase II and passed through a 40-μm nylon sieve. The 
cells and tubules were collected and cultured in DMEM/F12 medium 
containing 2% FCS, insulin (5 μg/ml), transferrin (5 μg/ml), selenium 
(5 ng/ml), hydrocortisone (40 ng/ml), and triiodothyronine (10–12 M). 
Nonpassaged cells cultured for 7 to 9 days were used for the experi-
ments described below.
Induction of RTEC stress. Thermal stress was induced by placing 
the RTECs at 4°C for 18 hours in full culture medium without FCS, fol-
lowed by a period of recovery, in which cells were incubated at 37°C 
Figure 7. Sugar specificity of CL-11 binding to stressed renal tubule cells. (A) Representative immunofluorescence images of bound rCL-11 in hypotherm-
ia-stressed Colec11–/– RTECs following incubation of the cells with rCL-11, which had been pretreated with PBS, L-fucose, or D-galactose, demonstrating that 
L-fucose–treated rCL-11 had reduced binding to the cells compared with that seen with PBS or D-galactose treatment. Scale bars: 10 μm. (B) Quantification 
of bound rCL-11 in the RTECs shown in A. Data shown are from 10 individual images and representative of 3 independent experiments. ****P < 0.001, by 
1-way ANOVA. (C) Representative fluorescence images of L-fucose (green) in hypothermia-stressed Colec11–/– RTECs following pretreatment of the cells 
with α-L-fucosidase or β-gal, as detected by the fluorescein-conjugated plant lectin LTL, demonstrating that fucosidase treatment reduced L-fucose resi-
dues on the cells. Scale bars: 12.5 μm. (D) Representative immunofluorescence images of bound rCL-11 (red) in the cells shown in C, which had been further 
incubated with rCL-11, demonstrating that fucosidase treatment reduced rCL-11 binding to the cells. Scale bars: 12.5 μm. (E) Quantification of bound rCL-11 
in the RTECs shown in D. Data shown are from 6 to 10 individual images and representative of 2 independent experiments. ****P < 0.001, by unpaired, 
2-tailed Student’s t test.
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Figure 8. Requirement of complement subcomponents for complement activation on tubule cells. (A) Representative immunofluorescence images 
of C3d deposits on hypothermia-stressed Colec11–/– RTECs following incubation with 10% fresh mouse serum from normal (NMS), Colec11–/–, Masp2–/–, 
or C4–/– mice, demonstrating C3d deposition following incubation with NMS and reduced deposition with Colec11–/– or Masp2–/– serum; in contrast, C3d 
deposition was not reduced following incubation with C4–/– serum. Scale bars: 25 μm. (B) Quantification of C3d deposits on the RTECs shown in A. Data 
shown are from 10 individual images for each of 4 independent experiments. Percentage of C3d-positive binding to Colec11–/– RTECs was determined 
from 5 to 7 individual fields, representative of 4 independent experiments, except for incubation with C4–/– serum, which was performed in 2 of those 
experiments. *P < 0.05, by 1-way ANOVA. (C) Representative fluorescence images of CL-11 (red), C3d (green), and a merged image of CL-11 and C3d 
in Colec11–/– RTECs that had been hypothermia stressed, pretreated with α-L-fucosidase or β-gal, and then incubated with NMS, demonstrating that 
CL-11 binding and C3d deposition were reduced by fucosidase treatment. A negative control of α-L-fucosidase–treated Colec11–/– RTECs, which had 
been incubated with Colec11–/– serum, is also shown. Scale bars: 25 μm. (D) Quantification of CL-11 binding and C3d deposition in the RTECs shown in C. 
Data shown are from 6 to 8 individual images and representative of 3 independent experiments. ****P < 0.001, by 2-way ANOVA. (E) Typical staining 
pattern for C3d on stressed Colec11–/– RTECs that had been incubated with medium alone or medium containing rCL-11 and then washed and subse-
quently incubated with Colec11–/– serum. (F) Quantification of C3d deposition in the RTECs shown in E. Data are from 6 individual images for each of 2 
independent experiments. **P < 0.01, by unpaired, 2-tailed Student’s t test.
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immunostained CL-11, L-fucose, NCC, and 
C3d in normal and ischemic mouse kidney tis-
sue. It was also used to determine the cellular 
location of deposited CL-11 on stressed cul-
tured Colec11–/– RTECs in relation to F-actin.
Semiquantitative real-time RT-PCR. Total 
RNA extraction from kidney tissue or cells, 
reverse transcription, cDNA synthesis, and 
PCR were performed as previously described 
(18). Relative gene expression was analyzed 
using the 2–ΔΔCt method (43) and expressed as 
2–ΔΔ (Ct), where Ct is the cycle threshold; ΔΔ 
(Ct) = test samples Δ (Ct) – control samples Δ 
(Ct); and Δ (Ct) = test gene (Ct) – 18s (Ct). RNA 
extracted from normal, nonmanipulated kid-
ney and nonstressed, cultured RTECs served 
as controls. The following primers were used 
for RT-PCR: murine Colec11: forward, 5′-TTC-




GATGT-3′; Gapdh: forward, 5′-ACCACAGTCCATGCCATCAC-3′ and 
reverse, 5′-TCCACCACCCTGTTGCTGTA-3′.
Flow cytometry. For detection of endogenous CL-11, single-cell 
suspensions of human proximal tubular epithelial cells (hPTECs) 
(a gift of L.C. Racusen, Department of Pathology, Johns Hopkins 
University School of Medicine, Baltimore, Maryland, USA) were 
fixed and permeabilized with Cytofix/Cytoperm (BD Biosciences). 
CL-11 staining was performed by preincubation of cells with mouse 
anti-CD16-CD32 mAb to block Fc receptors (clone 2.4G2; BD) and 
then incubated with polyclonal goat anti-human CL-11 Ab (1:100), 
which cross-reacts with mouse CL-11, followed by donkey anti-goat 
Alexa Fluor 568 Ab. For detection of exogenous CL-11 binding to 
the cells, single-cell suspensions of hPTECs were incubated with 
different doses of rCL-11 at 37°C for 1 hour, and the cells were then 
fixed with 4% paraformaldehyde (but not permeabilized) and sub-
jected to staining for CL-11. Stained cells were analyzed by flow 
cytometry using a FACSCalibur flow cytometer (BD Biosciences) 
and FlowJo software.
Statistics. Data are shown as the arithmetic mean ± SEM or as the 
readout for individual mice. An unpaired, 2-tailed Student’s t test was 
used for comparisons between 2 groups. A P value of less than 0.05 
was considered significant. One- or two-way ANOVA was used for 
comparisons between three or more groups. All analyses were per-
formed using GraphPad Prism, version 5 (GraphPad Software).
Study approval. The studies performed in animals were approved 
by the Animal Welfare and Ethical Review Body (AWERB) of King’s 
College London and were in accordance with the United Kingdom 
Animals (Scientific Procedures) Act of 1986.
Author contributions
CAF and DT designed and conducted in vivo and in vitro exper-
iments, performed data analysis, and helped write the manu-
script. KL contributed to the experimental design and performed 
in vitro experiments on human tubular cells. WW performed the 
confocal microscopy. QP cultured cells and performed in vitro 
stress as described above. Following the recovery period, cells were 
incubated with serum-free full culture medium supplemented with 
varying concentrations of rCL-11 at 37°C for 1 hour. Cells were then 
thoroughly washed and fixed with 4% paraformaldehyde (but not per-
meabilized) and subjected to immunofluorescence for CL-11.
Evaluation of CL-11 binding to RTECs through L-fucose. Two differ-
ent approaches were used: (a) assessment of the inhibition of CL-11 
binding to RTECs by pretreatment CL-11 with L-fucose; and (b) 
assessment of the inhibition of CL-11 binding to RTECs by removal 
of L-fucose from the surface of RTECs. For the first approach, rCL-11 
was incubated with either L-fucose (2 mg/ml) or D-galactose (2 mg/
ml) for 1 hour at room temperature and then applied in the assay of 
binding CL-11 to RTECs as described in the above section. For the 
second approach, Colec11–/– RTECs were treated with the enzyme 
α-L-fucosidase or control enzyme β-gal (0.1 U/ml) or buffer alone for 
1 hour at 37°C. After treatment, the RTECs were used for the assay of 
bound CL-11 as described in the above section.
Detection of CL-11 and C3d deposition on cultured RTECs. RTECs 
cultured from Colec11–/– kidneys were incubated with 10% serum 
from normal mice or Colec11–/–, Masp2–/–, or C4–/– mice at 37°C for 1 
hour. Heat-inactivated WT serum was used as a negative control. 
Cells were washed with PBS, fixed (but not permeabilized), and 
subjected to immunofluorescence for CL-11 and C3d as described 
earlier. Alternatively, RTECs cultured from Colec11–/– kidneys were 
incubated with rCL-11, washed, and then incubated with serum from 
Colec11–/– mice, washed again, and then stained for C3d.
Image analysis of CL-11 and C3d. Deposited CL-11 and C3d on 
cultured RTECs was visualized using an Olympus BX-51 microscope 
and quantified using ImageJ software (NIH). From each coverslip 
of stained cultured cells, 7–10 individual fields were photographed. 
The percentage of positive staining in each image was calculated 
automatically once the threshold adjustments had been determined 
to remove background signal.
Confocal microscopy. Confocal scanning electron microscopy was 
performed using a Nikon Eclipse Ti-E inverted microscope to detect 
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